We are the largest Polish manufacturer of drug products ranging from cardiological, gastrological and neurological applications.
Competing with the best in the branch, POLPHARMA is continuously changing, transforming itself into a modern generic company operating on a world stage. Our products are present in 50 countries. In 2007, POLPHARMA acquired a strategic stake in Akrihin, one of the leading Russian pharmaceutical companies.
Moreover, Polpharma has its representative offices in Lithuania, Belarus, Kazakhstan, the Ukraine and Vietnam. In the area of fine chemicals, POLPHARMA holds a strong |
 |
position in Europe and the USA. Together with the Medana Pharma Terpol Group, we are the Polish market leader by volume of drug packages sold.
Polpharma SA was founded in Starogard Gdański in 1935. Our company combines tradition and experience with modern technologies and the highest manufacturing standards.
Polpharma provides one-stop shopping solution of integrated services ranging from API development to finished dosage formulation and scale-up capabilities based on in-house or customer developed technology and support of the registration file.
position in Europe and the USA. |
|
Full support from molecule development to drug delivery
We offer:
. Development, production and marketing of generic APIs
. Custom synthesis and toll manufacturing
. Intellectual Property review services
. Non-infringing process development
. US and European DMFs in common format
. Wide reaction classes in FDA approved facilities
. Multipurpose production lines
. High GMP standards
. Product quality
|
|
|
